Patients are the first to feel the effects of medicines, yet many do not report the adverse events they experience. Renly Lim and Eyob Alemayehu Gebreyohannes share how a consumer-centred, co-designed digital approach can make ADR reporting easier in #UppsalaReports👇

As we age, we often rely on medications to manage our health. This makes us more vulnerable to #MedicationErrors. Learn more about the factors impacting elderly patients in the thread below👇 and read our #DeepDive into medication errors in #UppsalaReports 👉 ow.ly/F4q150W5qYF

🎥 We travel to Brazil🇧🇷 in the latest WHO PIDM in Focus film. Learn how @anvisaoficial.bsky.social, Instituto Butantan, and other local stakeholders are making use of UMC's tools and training to foster collaboration and harmonise safety data to ensure #PatientSafety below👇

Stay informed about all things #pharmacovigilance by listening to our podcast #DrugSafetyMatters. Some of our latest episodes cover: 🩻 Medical devices 🌐 The WHO Global Smart PV Strategy 🤖 Artificial intelligence in PV 🎧 Listen now at 👉 https://www.drugsafetymatterspod.org#pharmacovigilance#DrugSafetyMatters#AI #MedicalDevices

🔍 What is #pharmacovigilance? Reports of potential side effects from patients and healthcare professionals help us improve patient safety worldwide. Find out how the #MedSafetyCycle works in this illustrated story 👉 ow.ly/EoZ950LOJE4

Don't miss the 2nd #CIOMS webinar on #AI in PV. This edition is scheduled for audiences in the Asia-Pacific region and features UMC's Niklas Norén and expert panellists: 📆 Thursday, 26 March 🕣 08:30–10:00 IST / 20:00–21:30 PDT 📍 Online Register today 👉 https://ow.ly/5XSK50Ywazh

What if structured risk thinking started in the early phases of clinical development? Learn how development risk management plans (DRMP) can help shift the risk mindset to support better benefit–risk decision-making and #PatientSafety in #UppsalaReports:

#MedicationErrors are a leading cause of avoidable harm in healthcare, affecting millions of people worldwide each year. By understanding the different types of errors and finding effective ways to prevent them, we can improve the safety of medicines for everyone ✅ 👉 http://ow.ly/F4q150W5qYF

🎧 We're celebrating 50 000 downloads of the #DrugSafetyMatters podcast! 🎉 Thank you to our avid followers for tuning in and to our guest speakers for sharing their unique perspectives on topical issues in #pharmacovigilance. Listen to all episodes 👉 https://www.drugsafetymatterspod.org/

Historical data suggest that only 2–4% of non-serious and around 10% of serious adverse events are reported each year. Learn how a multi-modal approach is essential to breaking down barriers and addressing the complex web of factors driving underreporting today in #UppsalaReports👇

Malawi🇲🇼 has been a member of the WHO PIDM since 2016. Anderson Ndalama shares how #VigiFlow and #VigiMobile have strengthened #VaccineSafety reporting, improved efficiency, and significantly increased the number of AEFI reports submitted in the film below👇

🚺 This #InternationalWomensDay, we're celebrating how women are shaping the field of #pharmacovigilance. Read why our staff nominated Manal Younus, Marie Lindquist, Rachida Soulaymani Bencheikh, and Shanthi Pal as inspiring women in #pharmacovigilance in the photos below👇

A new preprint compares the design and scope of three rule-based algorithms developed to retrieve pregnancy-related adverse event reports across major #pharmacovigilance databases. 💬 Read the study and share your feedback here 👉 https://ow.ly/wI8F50Yq2Ry

Cross-functional collaboration among professionals in quality assurance, engineering, and drug safety is needed to ensure the safety of medical devices. 🎧 We chat #MedicalDevice safety with Omar Aimer, President of ISoP, in part 2 of this #DrugSafetyMatters episode 👉 https://ow.ly/y9WQ50Yp7sI

UMC's Niklas Norén will discuss the #CIOMS WG XIV report on #AI in PV and the chapters on validity/robustness and transparency. The webinar also features an expert panel discussion: 📆 Friday, 6 March 🕑 14:00–15:30 CET 📍 Online Spaces are limited. Register today 👉 https://ow.ly/X4FY50YnSCp

Rare diseases and #OrphanDrug monitoring represent a complex and evolving landscape in healthcare and pharmaceutical research. This #RareDiseaseDay, learn how a new era of innovation must be complemented by post-marketing surveillance in #UppsalaReports:

📖 Looking for a glossary of #pharmacovigilance terms and definitions? Version 2.4 of the #CIOMS Cumulative Glossary compiles all terms and definitions included in WG reports on pharmacovigilance. New to this edition is the inclusion of terms on #AI in PV👇

Disproportionality analysis is the go-to method in #pharmacovigilance, but it can easily be misused. How can we recognise common sources of error, mitigate biases, and interpret this scientific tool? 💬 #AskUsAnything – share your questions for @fusarolimichele.bsky.social and Eugene by 1 March👇

𝘋𝘪𝘥 𝘺𝘰𝘶 𝘬𝘯𝘰𝘸? #MedicationErrors aren't limited to just medicines. They can occur in these areas as well: 💉 Vaccines 🩸 Medical devices 💊 Supplements 🩺 Diagnostics We go beyond medicines in the thread below👇 Get the full scoop 👉 ow.ly/F4q150W5qYF

📖 A recent perspective piece in Clinical Pharmacology & Therapeutics, ft. contributions from @fusarolimichele.bsky.social, explores the rising misuse of #pharmacovigilance reporting systems and suggests pathways forward to conduct robust disproportionality analyses. #OpenAccess at the link below👇

Healthcare facilities across Brazil🇧🇷 are improving adverse event reporting, monitoring, and case management, with the help of #VigiFlow. 🎥 Andra Bori tells us how the InCor Heart Institute in São Paulo is utilising VigiFlow to implement effective safeguards in the film below👇

📚 In a new paper, UMC researchers provide an up-to-date profile of VigiBase, focusing on data capture and management, analysis tools, key database characteristics, and global trends and developments. Read the #OpenAccess article in the link below👇

How can we improve data access and data integration in #pharmacovigilance? A recent article in #DrugSafety outlines the findings of a focus group organised by the Drug Safety Research Unit IWG on New Developments in Pharmacovigilance. 📖 Read the #OpenAccess at the link below👇

Disproportionality analysis has become the workhorse of signal detection. However, published studies often overlook the inherent biases within adverse event reporting databases. Michele Fusaroli explores how #pharmacovigilance can move past crude disproportionality in #UppsalaReports👇

💘 Love isn't the only drug that can cause your Valentine to look funny. Report suspected side effects of medicines to your national regulator or healthcare professional to avoid seeing spots this #ValentinesDay. Learn what happens during the #MedSafetyCycle 👉 ow.ly/EoZ950LOJE4

💬 Can #psychedelic trip reports aid #pharmacovigilance systems in detecting safety concerns? This #UppsalaReports article details how #AI analysis of user narratives from online forums could help PV systems detect risks missed by traditional reporting👇

🎥 In a country as vast and diverse as Brazil 🇧🇷, coordinating safety surveillance across 27 states can be a challenge. Learn how #VigiFlow is helping @anvisaoficial.bsky.social to bridge this distance by strengthening safety surveillance and increasing reporting rates in the film below👇

👩‍🔬 Happy International Day of Women and Girls in Science! 🔬 #WomenInScience play a vital role in advancing scientific discovery, technology, and innovation. Discover why Anna, Bushra, and Valentina enjoy working in their scientific fields at UMC in the photos below👇 #EveryVoiceInScience #IDWGS

Pregnant patients are especially vulnerable to #MedicationErrors due to the potential impact on the patient's health and unborn baby. Learn more about the factors impacting pregnant patients in the thread below👇 and read our #DeepDive for more 👉 ow.ly/F4q150W5qYF

🎥 Malawi has been a member of the @who.int PIDM since 2016. Anderson Ndalama shares how #VigiFlow and #VigiMobile have strengthened vaccine safety reporting, improved efficiency, and fostered stronger collaboration between health agencies in the film below👇

From bandages to pacemakers, medical devices play a vital role in modern healthcare and in the daily lives of patients. In this two-part episode of #DrugSafetyMatters, Omar Aimer, breaks down medical device vigilance. Listen up 🎧 ow.ly/M36I50Y8JKZ #pharmacovigilance #MedicalDevices

As more young people turn to social media for health advice, introducing regular education on medication safety in schools could help address gaps in #HealthLiteracy and raise public awareness. Learn more in #UppsalaReports at the link below👇

A recent report by Michele Fusaroli, Joseph Mitchell, Annette Rudolph, Elena Rocco, and Riccardo Fusaroli, explores the cautious integration of directed acyclic graphs into disproportionality analyses to help synthesise evidence, map biases, and support more qualified causal hypotheses:

The @who.int has found that at least 1 in 20 patients (5%) experience preventable medication-related harm globally. Understanding the critical stages where medication errors occur is essential to preventing avoidable harm. Learn more about the critical stages in the thread below👇

What is your vision for #MedSafetyWeek? First-time participants Vietnam🇻🇳 and Mozambique🇲🇿 tell us why they decided to join the campaign and where they envision their pharmacovigilance communications initiatives heading in the future. More in #UppsalaReports 👉 https://ow.ly/FttZ50XTVG5

🎧 Catch up on recent #DrugSafetyMatters episodes and stay informed about some of the most pressing issues in the world of medicines safety. Our latest episodes explore: 🌐 The WHO Global Smart PV Strategy 🤖 #AI in pharmacovigilance 👧🏻 Paediatric PV Tune in 👉 https://www.drugsafetymatterspod.org

📚 New release – Version 9 of the #CIOMS Glossary of ICH Terms and definitions is now available. The glossary includes terms & definitions in the guidelines of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. Download your copy below👇

What makes a successful #MedSafetyWeek campaign? Mitul Jadeja of @mhragovuk.bsky.social has played a key role in MSW from the start. He shares his tips for campaign management, stakeholder collaboration, reaching target audiences, and more in #UppsalaReports 👉 https://ow.ly/h3Co50XTYIS

🎥 #VigiFlow combines national oversight with decentralised reporting to strengthen the safety surveillance of medicines and vaccines in Brazil🇧🇷. Learn how @anvisaoficial.bsky.social and local stakeholders are fostering a culture of #PatientSafety in a new 'WHO PIDM in Focus' film👇

Join UMC’s Niklas Norén and Eva-Lisa Meldau next month at #ISoPBasel2026🇨🇭 to learn more about emerging #AI technologies and human expertise in #pharmacovigilance, including trusted use of AI, case processing, and #LLMs. 📆 16–17 February 2026 Register today 👉 https://ow.ly/15gq50XWGFX

Underreporting in #pharmacovigilance remains a persistent global challenge. Learn how a multi-modal approach is essential to breaking down barriers and addressing the complex web of factors driving underreporting in the latest print issue of #UppsalaReports 👉 https://ow.ly/kEv050XSTmK

🎥 How is #VigiFlow shaping pharmacovigilance across the WHO PIDM? Manal Younus and Jaber Jaber share how they're utilising VigiFlow and connected applications to monitor the safety of medicines and vaccines in Iraq🇮🇶 and Jordan🇯🇴. Watch the film below for more👇

Children are more vulnerable to #MedicationErrors due to unclear dosing guidelines and a lack of child-specific medications. Learn more about the factors impacting child patients in the thread below👇 and read our #DeepDive for more 👉 ow.ly/F4q150W5qYF

Our beginner's guide to #pharmacovigilance covers the ABCs of PV, including: 🔹 What adverse reactions are 🔹 Preventing medication errors 🔹 National and global reporting systems ... and much more Download your copy here 👉 ow.ly/l5jQ50WXA6x

Since 2019, Invima Colombia has used #VigiFlow as its national safety surveillance database to monitor the safety of medicines and vaccines. We look behind the scenes into the intricacies of #pharmacovigilance in Colombia🇨🇴 in the film below👇

Two-thirds of pharmacists in Nigeria🇳🇬 witness weekly cough syrup abuse, yet poor reporting systems and unclear guidelines prevent effective intervention, leaving youths at risk.    Read what pharmacists think may help address medicine misuse in #UppsalaReports👇

With over 500 attendees from 80+ countries, #ISoP2025Cairo proved to be the place to discuss the evolution and future of #pharmcovigilance. From communication to falsified medicines and more, the 4-day event set an inspiring tone for the future of #PatientSafety. Read more in #UppsalaReports👇

It's time to reveal the number 1️⃣ #DrugSafetyMatters episode of 2025! 🎧 Our listeners were keen to hear how versatile generative #AI models are raising the bar for what's possible in #pharmacovigilance, and what's needed to regulate their use. Niklas Norén tells us more 👉 ow.ly/iRPq50Xq0xP

🔝 As we enter 2026, it's time to reveal the most read #UppsalaReports article of 2025! Coming in at number 1️⃣, our 𝘋𝘌𝘌𝘗 𝘋𝘐𝘝𝘌 on medication errors outlines the critical stages where they can occur, those most at risk, and how we can find effective ways to prevent them. Read more 👉 ow.ly/F4q150W5qYF

Coming in at number 2️⃣ on our #DrugSafetyMatters countdown for 2025 is Episode 36. Levente Pápai, Lovisa Sandberg, and Sara Vidlin discuss the complexities and challenges of pregnancy-related #pharmacovigilance and the VigiBase pregnancy algorithm. Listen now 🎧 ow.ly/bT8250VrmAK